---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-042811"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2026-04-13T23:59:59+00:00"
generated_at: "2026-05-15T06:35:58.367573+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BiomX accelerates option exercise, acquires 60% stake in DFSL for $750k cash, $3M note

## Summary
- Cash $750k, $3M convertible note (convertible at $12), 923k shares, and warrants for up to 4.6M shares at $12.
- Revenue bonus: 5% of annual revenues if DFSL exceeds $25M in any fiscal year from 2027; payable in stock or cash.
- DFSL develops LADAR-based detection systems for counter-UAS and perimeter security; deployed in Israel, Africa, and LA Metro.
- Transaction subject to Israeli regulatory approval and NYSE American stockholder approval.
- Acquisition follows prior purchase of Zorronet AI platform; technologies designed to integrate detection, analysis, and response.

## SEC filing metadata
- accession: 0001213900-26-042811
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2026-04-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390026042811/0001213900-26-042811-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390026042811/ea0285293-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-042811
- JSON: https://secwatch.observer/filing/0001213900-26-042811.json
- Plain text: https://secwatch.observer/filing/0001213900-26-042811.txt

## Source-grounded claims
- claim_id: b2ab8b884c8e95449e0b3ec94d1aabe4c923752c
  claim: BiomX Inc. completed an acquisition involving Mandragola Ltd for a cash payment of Seven Hundred Fifty Thousand Dollars ($750,000); the issuance of an unsecured convertible promissory note in the principal amount of Three Mil (closed 2026-04-13).
  evidence_excerpt: delivery. In consideration for the Purchased Shares, the Company agreed to the following consideration to Mandragola: (i) a cash payment of Seven Hundred Fifty Thousand Dollars ($750,000), of which Four Hundred Fifty Thousand ($450,000) was advanced by the Company; (ii) the issuance of an unsecured convertible promissory note in the principal amount of Three
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390026042811/0001213900-26-042811-index.htm
- claim_id: 391dcadedb674f0c7a8f7765dd16c18955b34659
  claim: BiomX Inc. entered into Stock Purchase & Assignment Agreement with Mandragola Ltd (effective 2026-04-13).
  evidence_excerpt: On April 13, 2026, the Company entered into and simultaneously closed on a Stock Purchase & Assignment Agreement (the “SPA”) with Mandragola
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390026042811/0001213900-26-042811-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.